SI-Bone (SIBN) has shared an announcement.
Daniel Wolf has been elected as a director of the Company by its board, starting from August 5, 2024. He brings extensive experience from Baxter International, Medtronic plc, and previous board roles in healthcare-related companies, along with a strong academic background from Bowdoin College, Harvard Business School, and MIT. As a non-employee director, he’ll earn a $45,000 annual cash retainer, be granted restricted stock units, and benefit from an indemnification agreement without any material conflicts of interest disclosed.
For detailed information about SIBN stock, go to TipRanks’ Stock Analysis page.
